big us rally in biotechs and drugs Biotechs like SRX are extremely undervalued by US standards and I would not be surprised if US co (like Cephalon did 2 years ago and bid 4.85 for Sirtex), try to take over Sirtex with sp near 4 year lows and making over 130% revenue growth and profits tripling from a year ago. Most likely candidates would be Pfizer up 10% today and Sanofi who both have partnerships with Sirtex.
topper's finally got some new material, page-58
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
0.005(3.23%) |
Mkt cap ! $67.91M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 16.0¢ | 15.5¢ | $504.2K | 3.157M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 1459355 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 406509 | 5 |
View Market Depth
| Last trade - 16.10pm 08/07/2024 (20 minute delay) ? |
| SRX (ASX) Chart |